AU2003232315A1 - Sarcosyl buffer and its use for the purification of prion protein - Google Patents

Sarcosyl buffer and its use for the purification of prion protein

Info

Publication number
AU2003232315A1
AU2003232315A1 AU2003232315A AU2003232315A AU2003232315A1 AU 2003232315 A1 AU2003232315 A1 AU 2003232315A1 AU 2003232315 A AU2003232315 A AU 2003232315A AU 2003232315 A AU2003232315 A AU 2003232315A AU 2003232315 A1 AU2003232315 A1 AU 2003232315A1
Authority
AU
Australia
Prior art keywords
purification
prion protein
sarcosyl
buffer
sarcosyl buffer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003232315A
Inventor
Anthony Russel Clarke
John Collinge
Simon Hawke
Graham Stuart Jackson
Jonathan D. F. Wadsworth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0210365A external-priority patent/GB0210365D0/en
Priority claimed from GB0210497A external-priority patent/GB0210497D0/en
Priority claimed from GB0210747A external-priority patent/GB0210747D0/en
Priority claimed from GB0211116A external-priority patent/GB0211116D0/en
Priority claimed from GB0211220A external-priority patent/GB0211220D0/en
Priority claimed from GB0211889A external-priority patent/GB0211889D0/en
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of AU2003232315A1 publication Critical patent/AU2003232315A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003232315A 2002-05-07 2003-05-07 Sarcosyl buffer and its use for the purification of prion protein Abandoned AU2003232315A1 (en)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
GB0210365A GB0210365D0 (en) 2002-05-07 2002-05-07 Composition and method
GB0210365.3 2002-05-07
GB0210497A GB0210497D0 (en) 2002-05-08 2002-05-08 Composition and method
GB0210497.4 2002-05-08
GB0210747A GB0210747D0 (en) 2002-05-10 2002-05-10 Composition and method
GB0210747.2 2002-05-10
GB0211116.9 2002-05-15
GB0211116A GB0211116D0 (en) 2002-05-15 2002-05-15 Composition and method
GB0211220A GB0211220D0 (en) 2002-05-16 2002-05-16 Composition and method
GB0211220.9 2002-05-16
GB0211889A GB0211889D0 (en) 2002-05-23 2002-05-23 Composition and method
GB0211889.1 2002-05-23
PCT/GB2003/001951 WO2003096023A1 (en) 2002-05-07 2003-05-07 Sarcosyl buffer and its use for the purification of prion protein

Publications (1)

Publication Number Publication Date
AU2003232315A1 true AU2003232315A1 (en) 2003-11-11

Family

ID=29424872

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003232315A Abandoned AU2003232315A1 (en) 2002-05-07 2003-05-07 Sarcosyl buffer and its use for the purification of prion protein

Country Status (2)

Country Link
AU (1) AU2003232315A1 (en)
WO (1) WO2003096023A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0718603D0 (en) * 2007-09-24 2007-10-31 Medical Res Council Methods
DE102017130356A1 (en) 2017-12-18 2019-06-19 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Method for separating various Abeta peptides by gel electrophoresis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19937219A1 (en) * 1999-08-06 2001-02-08 Aventis Behring Gmbh Process for the pure presentation of the protease activating the blood coagulation factor VII, its proenzyme or a mixture of both proteins by means of ion exchange chromatography

Also Published As

Publication number Publication date
WO2003096023A1 (en) 2003-11-20

Similar Documents

Publication Publication Date Title
IL262513A (en) Protein purification
AU2003201727A1 (en) Recombinant protein expression
AU2003272454A1 (en) Protein purification
AU2003226899A1 (en) Human diabetes-mediating proteins
AU2003282338A1 (en) Determination of protein function
AU2003205623A1 (en) Prion protein carrier-conjugates
AU2003207628A1 (en) Structural and cytoskeleton-associated proteins
AU2003232315A1 (en) Sarcosyl buffer and its use for the purification of prion protein
AU2002341828A1 (en) Enhanced proteins and methods for their use
AU2003262638A1 (en) Biotinylation of proteins
AU2003202694A1 (en) Torero protein
AU2003292774A1 (en) Novel proteins and use thereof
AU2003280992A1 (en) Novel proteins and use thereof
AU2003278718A1 (en) Stars-a muscle-specification-binding protein
AU2003228944A1 (en) Protein complex purification
AU2003213933A1 (en) Purified polypeptides involved in protein synthesis and modification
AU2003248597A1 (en) The purification of 2-methoxy-5-trifluoromethoxybenzaldehyde
AU2003290331A1 (en) Protein purification means
AU2002319589A1 (en) Buffers for electrophoresis and use thereof
GB0323609D0 (en) A peptide,and use of the peptide to assay for sflt-1 protein
AU2003263751A1 (en) Novel proteins and their uses
AU2003265814A1 (en) Aw755252-interacting proteins and use thereof
AU2003229752A1 (en) Human rhomboid-related protein
AU2003254865A1 (en) Akt2-BINDING PROTEIN
AU2003276470A1 (en) Alpha macroglobulin family member

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 18, NO 2, PAGE(S) 548 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME MEDICALRESEARCH COUNCIL, APPLICATION NO. 2003232315, UNDER INID (43) CORRECT THE PUBLICATION DATE TO READ 24.11.2003